The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“that is attributed to a negative synergistic effect [97]”
From The Use of Medications and Dietary Supplements by Masters Athletes—A Review (2022) · cites this paper as [97]
In the citing paper
“Caffeine alone did not have this effect [97].”
From The Use of Medications and Dietary Supplements by Masters Athletes—A Review (2022) · cites this paper as [97]
In the citing paper
“higher caffeine intake when used concurrently with creatine supplementation in people living and medicated for Parkinson disease has been associated with a significantly faster progression of the disease”
From The Use of Medications and Dietary Supplements by Masters Athletes—A Review (2022) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Hamza, T. H., Chen, H., Hill-Burns, E. M., Rhodes, S. L., Montimurro, J., Kay, D. M., Tenesa, A., Kusel, V. I., Sheehan, P., Eaaswarkhanth, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002237 · Cited by 218
Research works printed but not linked: 15
- Fernandez-Duenas, 2014, Uncovering caffeines adenosine A2A receptor inverse agonism in experimental parkinsonism., ACS Chem Biol, 9, 2496, 10.1021/cb5005383 · DOI
- Kachroo, 2012, Adenosine A2A receptor gene disruption protects in an -synuclein model of Parkinsons disease., Ann Neurol, 71, 278, 10.1002/ana.22630 · DOI
- 2006, A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease., Neurology, 66, 664, 10.1212/01.wnl.0000201252.57661.e1 · DOI · Paper page
- 2007, A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease., Neurology, 68, 20, 10.1212/01.wnl.0000250355.28474.8e · DOI
- Simon, 2008, Caffeine and progression of Parkinson disease., Clin Neuropharmacol, 31, 189, 10.1097/WNF.0b013e31815a3f03 · DOI
- Morelli, 2010, Pathophysiological roles for purines: adenosine, caffeine and urate., Prog Brain Res, 183, 183, 10.1016/S0079-6123(10)83010-9 · DOI
- Bentley, 2014, Rare POLG1 CAG variants do not influence Parkinsons disease or polymerase gamma function., Mitochondrion, 15, 65, 10.1016/j.mito.2014.01.004 · DOI
- McGuine, 2001, Creatine supplementation in high school football players., Clin J Sport Med, 11, 247, 10.1097/00042752-200110000-00007 · DOI · Paper page
- Postuma, 2012, Caffeine for treatment of Parkinson disease: a randomized controlled trial., Neurology, 79, 651, 10.1212/WNL.0b013e318263570d · DOI · Paper page
- Hespel, 2002, Opposite actions of caffeine and creatine on muscle relaxation time in humans., J Appl Physiol, 92, 513, 10.1152/japplphysiol.00255.2001 · DOI · Paper page
- Vandenberghe, 1996, Caffeine counteracts the ergogenic action of muscle creatine loading., J Appl Physiol, 80, 452, 10.1152/jappl.1996.80.2.452 · DOI · Paper page
- Choi, 2007, Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey., Arthritis Rheum, 57, 816, 10.1002/art.22762 · DOI
- Swanson, 1994, Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal., Addict Behav, 19, 229, 10.1016/0306-4603(94)90027-2 · DOI
- Tanner, 2009, Occupation and risk of parkinsonism: a multicenter case-control study., Arch Neurol, 66, 1106, 10.1001/archneurol.2009.195 · DOI · Paper page
- Addicott, 2009, Methodological considerations for the quantification of self-reported caffeine use., Psychopharmacology (Berl), 203, 571, 10.1007/s00213-008-1403-5 · DOI
Cited by
Caffeine as a factor influencing the functioning of the human body-friend or foe?
Rodak, K., Kokot, I., & Kratz, E. M. (2021) · Nutrients · doi:10.3390/nu13093088 · Cited by 188
Beyond muscles: The untapped potential of creatine
Riesberg, L. A., Weed, S. A., McDonald, T. L., Eckerson, J. M., & Drescher, K. M. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2015.12.034 · Cited by 95
Creatine and creatine forms intended for sports nutrition
Andres, S., Ziegenhagen, R., Trefflich, I., Pevny, S., Schultrich, K., Braun, H., Schänzer, W., Hirsch‐Ernst, K. I., Schäfer, B., & Lampen, A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600772 · Cited by 54
Chen, J.-F., & Schwarzschild, M. A. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.10.024 · Cited by 39
The Use of Medications and Dietary Supplements by Masters Athletes—A Review
Harnett, J., Climstein, M., Walsh, J., & Gifford, J. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00398-0 · Cited by 12
Metadata
- Authors
- Simon, D. K., Wu, C., Tilley, B. C., Wills, A.-M., Aminoff, M. J., Bainbridge, J., Hauser, R. A., Schneider, J. S., Sharma, S., Singer, C., Tanner, C. M., Truong, D., & Wong, P. S.
- Venue
- Clinical Neuropharmacology
- Published
- 2015-09
- Volume
- 38
- Issue
- 5
- Pages
- 163-169
- ISSN
- 0362-5664
- Cited by
- 26
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. https://app.cochat.ai/papers/10.1097/wnf.0000000000000102
- The paper
- Simon, D. K., Wu, C., Tilley, B. C., Wills, A.-M., Aminoff, M. J., Bainbridge, J., Hauser, R. A., Schneider, J. S., Sharma, S., Singer, C., Tanner, C. M., Truong, D., & Wong, P. S. (2015). Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
